Testosterone scripts for women rise with denials, delays

Prescriptions for testosterone among women are increasing, primarily driven by its off-label use to treat symptoms associated with menopause. Despite this rising trend in medical scripts, patients are frequently encountering significant obstacles, including insurance denials and processing delays. This growth in usage highlights a shift in managing menopausal health, although the administrative hurdles persist for many women seeking this specific treatment. The trend reflects a growing reliance on off-label hormone therapy for symptom relief.